Cell-Molecule Circuitry of Hepatobiliary Repair 

Description

In this session, panel members discuss recent advances in understanding the cellular and molecular basis of hepatobiliary repair. The concepts covered by thought leaders and content experts include the roles of various metabolic zones in the liver lobule in maintaining hepatic homeostasis as well as in regeneration following injury or resection; and the balance of metabolic/synthetic function and proliferation during liver repair and what controls such balance. Presenters also address the concepts of hepatocyte to cholangiocyte reprogramming and vice versa (ie, transdifferentiation) during specific chronic pathologies affecting cholangiocytes and hepatocytes, respectively. Finally, panelists review synthetic biology approaches including the use of personalized hepatic organoids and gene editing for understanding rare and orphan liver diseases.

Presentations

2:00 PM - 2:15 PM
Nov 16 2024
San Diego, CA

Zonal Imbalance and Impact on Liver Repair

Satdarshan (Paul) Monga, MD, FAASLD, Presenter
Acute Liver Failure
Acute-on-Chronic Liver Failure
2:15 PM - 2:30 PM
Nov 16 2024
San Diego, CA

Zonal Dilemma of Liver Homeostasis and Regeneration

Hao Zhu, MD, Presenter
Acute Liver Failure
Acute-on-Chronic Liver Failure
2:30 PM - 2:45 PM
Nov 16 2024
San Diego, CA

Hepatocyte to Biliary Epithelial Cell Transdifferentiation in Liver Repair

Stacey S Huppert, PhD, Presenter
Acute Liver Failure
Acute-on-Chronic Liver Failure
2:45 PM - 3:00 PM
Nov 16 2024
San Diego, CA

Biliary Epithelial Cell to Hepatocyte Transdifferentiation in Liver Repair

Valerie VG Gouon-Evans, PharmD, PhD, Presenter
Acute Liver Failure
Acute-on-Chronic Liver Failure
3:00 PM - 3:15 PM
Nov 16 2024
San Diego, CA

Synthetic Biology Approaches to Studying Rare Liver Diseases

Silvia Vilarinho, MD, PhD, Presenter
Acute Liver Failure
Acute-on-Chronic Liver Failure

Objectives

  • Discuss recent advances in the synthetic biology based concepts of studying liver diseases using CRISPR, and personalized patient-derived or patient-mimicking liver organoid models.
  • Explain the concepts of hepatocyte to biliary and biliary to hepatocyte transdifferentiation with respect to improving care of patients with either cholangiopathies or primarily hepatocyte damaging pathologies, respectively.
  • Review the proliferative and reparative capacities of various metabolic zones of a liver lobule following injury.
Chair

Enis Kostallari, PhD, MS

Mayo Clinic Rochester
Chair

Kari Nejak-Bowen, MBA, PhD

University of Pittsburgh